RA Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
RA Capital Management's AMLX Position: Q3 2026 in Review
RA Capital Management opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 4,279,341 shares worth $125M. The stake represents 1.25% of the portfolio and ranks #20 among its holdings.
217 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- RA Capital Management held 4,279,341 shares of Amylyx Pharmaceuticals worth $125M as of Q3 2026.
- Amylyx Pharmaceuticals was a new RA Capital Management position in Q3 2026.
- Amylyx Pharmaceuticals made up 1.25% of RA Capital Management's portfolio in Q3 2026, its #20 holding.
- 217 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on RA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.